What changed in Keurig Dr Pepper's 10-K — 2023 vs 2024
Paragraph-level year-over-year comparison of Keurig Dr Pepper's 2023 and 2024 10-K annual filings, covering the Business, Risk Factors, Legal Proceedings, Cybersecurity, MD&A and Market Risk sections. Every new, removed and edited paragraph is highlighted side-by-side so you can see exactly what management changed in the 2024 report.
Top changes in Keurig Dr Pepper's 2024 10-K
263 paragraphs added · 320 removed · 204 edited across 8 sections
- Item 7. Management's Discussion & Analysis+99 / −140 · 72 edited
- Item 1. Business+66 / −80 · 49 edited
- Item 1A. Risk Factors+75 / −74 · 62 edited
- Item 7A. Quantitative and Qualitative Disclosures About Market Risk+9 / −9 · 9 edited
- Item 5. Market for Registrant's Common Equity+6 / −6 · 4 edited
Item 1. Business
Business — how the company describes what it does
49 edited+17 added−31 removed37 unchanged
Item 1. Business
Business — how the company describes what it does
… 17 more changes not shown on this page.
Item 1A. Risk Factors
Risk Factors — what could go wrong, per management
62 edited+13 added−12 removed122 unchanged
Item 1A. Risk Factors
Risk Factors — what could go wrong, per management
… 7 more changes not shown on this page.
Item 1C. Cybersecurity
Cybersecurity — threats and controls disclosure
4 edited+0 added−0 removed7 unchanged
Item 1C. Cybersecurity
Cybersecurity — threats and controls disclosure
Item 2. Properties
Properties — owned and leased real estate
3 edited+0 added−1 removed1 unchanged
Item 2. Properties
Properties — owned and leased real estate
Item 3. Legal Proceedings
Legal Proceedings — active lawsuits and investigations
1 edited+0 added−2 removed0 unchanged
Item 3. Legal Proceedings
Legal Proceedings — active lawsuits and investigations
Item 5. Market for Registrant's Common Equity
Market for Common Equity — stock, dividends, buybacks
4 edited+2 added−2 removed0 unchanged
Item 5. Market for Registrant's Common Equity
Market for Common Equity — stock, dividends, buybacks
Item 7. Management's Discussion & Analysis
Management's Discussion & Analysis (MD&A) — revenue / margin commentary
72 edited+27 added−68 removed35 unchanged
Item 7. Management's Discussion & Analysis
Management's Discussion & Analysis (MD&A) — revenue / margin commentary
… 87 more changes not shown on this page.
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
Market Risk — interest-rate, FX, commodity exposure
9 edited+0 added−0 removed5 unchanged
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
Market Risk — interest-rate, FX, commodity exposure